During this panel discussion, our speakers will talk through common applications of RWD in drug development, how AI/ML techniques in RWD analyses are helping patients, carers and policy makers to drive better patient outcomes, and challenges their organizations are working to solve related to the use of AI in RWD.
COO, Customer Success & Data Science, BC Platforms
Chief Strategy Officer, Eleven Therapeutics
Head of Estonian Biobank Innovation Center
Real World Evidence Leader – Oncology, AstraZencea
Maria Del Pilar Schneider
Senior Data Mining Statistician, IPSEN Innovation